Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1998 1
1999 6
2000 25
2001 29
2002 42
2003 33
2004 57
2005 66
2006 58
2007 68
2008 64
2009 75
2010 110
2011 99
2012 98
2013 95
2014 100
2015 127
2016 129
2017 111
2018 138
2019 78
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

1,445 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic developments for Duchenne muscular dystrophy.
Verhaart IEC, Aartsma-Rus A. Verhaart IEC, et al. Nat Rev Neurol. 2019 Jul;15(7):373-386. doi: 10.1038/s41582-019-0203-3. Nat Rev Neurol. 2019. PMID: 31147635 Review.
Duchenne muscular dystrophy: an updated review of common available therapies.
Salmaninejad A, Valilou SF, Bayat H, Ebadi N, Daraei A, Yousefi M, Nesaei A, Mojarrad M. Salmaninejad A, et al. Int J Neurosci. 2018 Sep;128(9):854-864. doi: 10.1080/00207454.2018.1430694. Epub 2018 Feb 5. Int J Neurosci. 2018. PMID: 29351004 Review.
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Bushby K, et al. Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27. Lancet Neurol. 2010. PMID: 19945913 Review.
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy.
Nelson CE, Wu Y, Gemberling MP, Oliver ML, Waller MA, Bohning JD, Robinson-Hamm JN, Bulaklak K, Castellanos Rivera RM, Collier JH, Asokan A, Gersbach CA. Nelson CE, et al. Nat Med. 2019 Mar;25(3):427-432. doi: 10.1038/s41591-019-0344-3. Epub 2019 Feb 18. Nat Med. 2019. PMID: 30778238 Free PMC article.
Duchenne muscular dystrophy: an historical treatment review.
Werneck LC, Lorenzoni PJ, Ducci RD, Fustes OH, Kay CSK, Scola RH. Werneck LC, et al. Arq Neuropsiquiatr. 2019 Sep 5;77(8):579-589. doi: 10.1590/0004-282X20190088. Arq Neuropsiquiatr. 2019. PMID: 31508685 Free article. Review.
Eteplirsen in the treatment of Duchenne muscular dystrophy.
Lim KR, Maruyama R, Yokota T. Lim KR, et al. Drug Des Devel Ther. 2017 Feb 28;11:533-545. doi: 10.2147/DDDT.S97635. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28280301 Free PMC article. Review.
Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
Amoasii L, Hildyard JCW, Li H, Sanchez-Ortiz E, Mireault A, Caballero D, Harron R, Stathopoulou TR, Massey C, Shelton JM, Bassel-Duby R, Piercy RJ, Olson EN. Amoasii L, et al. Science. 2018 Oct 5;362(6410):86-91. doi: 10.1126/science.aau1549. Epub 2018 Aug 30. Science. 2018. PMID: 30166439 Free PMC article.
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Bushby K, et al. Lancet Neurol. 2010 Feb;9(2):177-89. doi: 10.1016/S1474-4422(09)70272-8. Epub 2009 Nov 27. Lancet Neurol. 2010. PMID: 19945914 Review.
1,445 results
Jump to page
Feedback